Melanoma Research | search
Click here to view Melanoma Research news from 60+ newspapers.
Bookmark or Share- TIL Therapy: A New Melanoma Treatment 30 Years in the MakingLifileucel (Amtagvi), a tumor-infiltrating lymphocyte (TIL) therapy, is a first-of-its-kind personalized immunotherapy that amplifies the cancer-fighting immune cells already present in a patient’s melanoma. Lifileucel is the first TIL therapy to be approved for clinical use and the first cell-based immunotherapy to be approved for a solid tumor.
- Melanoma and Other Skin Cancers Research Results and Study UpdatesMelanoma and Other Skin Cancers Research Results and Study Updates. See Advances in Melanoma and Other Skin Cancers Research for an overview of recent findings and progress, plus ongoing projects supported by NCI. First Cancer TIL Therapy Gets FDA Approval for Advanced Melanoma. Posted: March 5, 2024.
- Melanoma ResearchMelanoma Research. Current Issue. October 2023 - Volume 33 - Issue 5. Editor-in-Chief:F.J. Lejeune W.J. Storkus. ISSN:0960-8931. Online ISSN:1473-5636. Frequency:6 issues / year. Ranking:44 of 70 Dermatology106 of 136 Medicine, Research & Experimental199 of 241 Oncology. Impact Factor:2.2. eTOC Alert. Current Issue Highlights. Original Articles.
- Home - Melanoma Research FoundationMelanoma is the deadliest form of skin cancer. Melanoma claims the lives of over 8,290 Americans every year. Melanoma is the leading cause of cancer death in young women ages 25 – 30 and the second leading cause of cancer death in women ages 30-35.
- Signal pathways of melanoma and targeted therapy - NatureWeinan Guo, Huina Wang & Chunying Li. Signal Transduction and Targeted Therapy 6, Article number: 424 ( 2021 ) Cite this article. 23k Accesses. 115 Citations. 10 Altmetric. Metrics. Abstract....
More
